Amgen Says IRS Seeks $7.1 Billion in Back Taxes, Penalties

The IRS claims relate to the way the biotech company allocates profits between Puerto Rico, where it has significant manufacturing operations, and the U.S. mainland, where it is based.

The IRS claims relate to the way the biotech company allocates profits between Puerto Rico, where it has significant manufacturing operations, and the U.S. mainland, where it is based.

Source: Read More

PAID

Leave a Comment